Raheem O A, Casey R G, Attah C, Clarke L, McGrath A, Gaffney E, Hollywood D, McDermott T E D, Lynch T H
Department of Urology, St James's Hospital, Dublin, Ireland.
Can J Urol. 2009 Dec;16(6):4941-5.
Squamous cell carcinoma of the prostate gland is very rare, constituting 0.5%-1% of all prostatic malignancies. Though it has a similar clinical presentation to prostate cancer, the tumor is more aggressive, spreading to bone, liver and lung. The median survival time is approximately 14 months. Diagnosis is exclusively by histology. Therapeutic options may include radical surgery, radiotherapy, chemotherapy, hormonal therapy or a combination of these treatments. We present a case of locally advanced squamous cell carcinoma of the prostate and comment on its management and subsequent disease related complication.
前列腺鳞状细胞癌非常罕见，占所有前列腺恶性肿瘤的0.5%-1%。尽管其临床表现与前列腺癌相似，但该肿瘤侵袭性更强，会扩散至骨骼、肝脏和肺部。中位生存时间约为14个月。诊断完全依靠组织学检查。治疗选择可能包括根治性手术、放疗、化疗、激素治疗或这些治疗方法的联合应用。我们报告一例局部晚期前列腺鳞状细胞癌病例，并对其治疗及随后的疾病相关并发症进行讨论。
